Narrow‐band ultraviolet B phototherapy versus broad‐band ultraviolet B or psoralen‐ultraviolet A photochemotherapy for psoriasis
Referencias
Additional references
Anderson TF, Waldinger TP, Voorhees JJ. UV‐B phototherapy. An overview. Archives of Dermatology 1984;120(11):1502‐7.
Ashworth J, Kahan MC, Breathnach SM. PUVA therapy decreases HLA‐DR+ CDIa+ Langerhans cells and epidermal cell antigen‐presenting capacity in human skin, but flow cytometrically‐sorted residual HLA‐DR+ CDIa+ Langerhans cells exhibit normal alloantigen‐presenting function. British Journal of Dermatology 1989;120(3):329‐39.
Aubin F, Humbert P. Immunomodulation induced by psoralen plus ultraviolet A radiation. European Journal of Dermatology 1998;8(3):212‐3.
Aufiero BM, Talwar H, Young C, Krishnan M, Hatfield JS, Lee HK, et al. Narrow‐band UVB induces apoptosis in human keratinocytes. Journal of Photochemistry & Photobiology 2006;82(2):132‐9.
Boer J, Schothorst AA, Suurmond D. UV‐B phototherapy of psoriasis. Dermatologica 1980;161(4):250‐8.
Boer J, Hermans J, Schothorst AA, Suurmond D. Comparison of phototherapy (UV‐B) and photochemotherapy (PUVA) for clearing and maintenance therapy of psoriasis. Archives of Dermatology 1984;120(1):52‐7.
Boffetta P, Gridley G, Lindelof B. Cancer risk in a population‐based cohort of patients hospitalized for psoriasis in Sweden. Journal of Investigative Dermatology 2001;117(6):1531‐7.
Borroni G, Zaccone C, Vignati G, Fietta A, Gatti M, Brazzelli V, et al. Lymphopenia and decrease in the total number of circulating CD3+ and CD4+ T cells during 'long‐term' PUVA treatment for psoriasis. Dermatologica 1991;183(1):10‐4.
Brenner W, Jaschke E, Honigsmann H. [UV‐B phototherapy in psoriasis]. Zeitschrift fur Hautkrankheiten 1983;58(15):1113‐24.
Coven TR, Burack LH, Gilleaudeau R, Keogh M, Ozawa M, Krueger JG. Narrowband UV‐B produces superior clinical and histopathological resolution of moderate‐to‐severe psoriasis in patients compared with broadband UV‐B. Archives of Dermatology 1997;133(12):1514‐22.
Coven TR, Walters IB, Cardinale I, Krueger JG. PUVA‐induced lymphocyte apoptosis: mechanism of action in psoriasis. Photodermatology, Photoimmunology & Photomedicine 1999;15(1):22‐7.
Dawe RS, Cameron H, Yule S, Man I, Wainwright NJ, Ibbotson SH, et al. A randomized controlled trial of narrowband ultraviolet B vs bath‐psoralen plus ultraviolet A photochemotherapy for psoriasis. British Journal of Dermatology 2003;148(6):1194‐204.
De Gruijl FR. Long‐term side effects and carcinogenesis risk in UVB therapy. In: Honigsmann H, Jori G, Young AR editor(s). The Fundamental Bases of Photo‐therapy. Milan, Italy: OEMF, 1996:153‐70.
Fischer T. UV‐light treatment of psoriasis. Acta Dermato‐Venereologica 1976;56:473‐9.
Gelfand JM, Berlin J, Van Voorhees A, Margolis DJ. Lymphoma rates are low but increased in patients with psoriasis: results from a population‐based cohort study in the United Kingdom. Archives of Dermatology 2003;139(11):1425‐9.
Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA 2006;296(14):1735‐41.
Gordon PM, Diffey BL, Matthews JN, Farr PM. A randomized comparison of narrow‐band TL‐01 phototherapy and PUVA photochemotherapy for psoriasis. Journal of the American Academy of Dermatology 1999;41(5 Part 1):728‐32.
Green C, Ferguson J, Lakshmipathi T, Johnson BE. 311 nm UVB phototherapy‐‐an effective treatment for psoriasis. British Journal of Dermatology 1988;119(6):691‐6.
Griffiths CE, Voorhees JJ. Psoriasis, T cells and autoimmunity. Journal of the Royal Society of Medicine 1996;89(6):315‐9.
Hannuksela‐Svahn A, Pukkala E, Laara E, Poikolainen K, Karvonen J. Psoriasis, its treatment, and cancer in a cohort of Finnish patients. Journal of Investigative Dermatology 2000;114(3):587‐90.
Higgins JPT, Green S, (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated September 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Honigsmann H, Fritsch P, Jaschke E. [UV‐therapy of psoriasis. Half‐side comparison between oral photochemotherapy (PUVA) and selective UV‐phototherapy (SUP)]. Zeitschrift fur Hautkrankheiten 1977;52(21):1078‐82.
Jensen P, Skov L, Zachariae C. Systemic combination treatment for psoriasis: a review. Acta Dermato‐Venereologica 2010;90(4):341‐9.
Kozenitzky L, David M, Sredai B, Albeck M, Shohat B. Immunomodulatory effects of AS101 on interleukin‐2 production and T‐lymphocyte function of lymphocytes treated with psoralens and ultraviolet A. Photodermatology, Photoimmunology & Photomedicine 1992;9(1):24‐8.
Lauharanta J. Photochemotherapy. Clinics in Dermatology 1997;15(5):769‐80.
Markham T, Rogers S, Collins P. Narrowband UV‐B (TL‐01) phototherapy vs oral 8‐methoxypsoralen psoralen‐UV‐A for the treatment of chronic plaque psoriasis. Archives of Dermatology 2003;139(3):325‐8.
Morison WL. Combination of methoxsalen and ultraviolet B (UVB) versus UVB radiation alone in treatment of psoriasis: a bilateral comparison study. Photodermatology, Photoimmunology & Photomedicine 1995;11(1):6‐8.
Morison WL, Baughman RD, Day RM, Forbes PD, Hoenigsmann H, Krueger GG, et al. Consensus workshop on the toxic effects of long‐term PUVA therapy. Archives of Dermatology 1998;134(5):595‐8.
Neuner P, Charvat B, Knobler R, Kirnbauer R, Schwarz A, Luger T A, et al. Cytokine release by peripheral blood mononuclear cells is affected by 8‐methoxypsoralen plus UV‐A. Photochemistry & Photobiology 1994;59(2):182‐8.
Parrish JA, Jaenicke KF. Action spectrum for phototherapy of psoriasis. Journal of Investigative Dermatology 1981;76(5):359‐62.
Smith CH, Anstey AV, Barker JN, Burden AD, Chalmers RJ, Chandler DA, et al. British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009. British Journal of Dermatology 2009;161(5):987‐1019.
Storbeck K, Holzle E, Schurer N, Lehmann P, Plewig G. Narrow‐band UVB (311 nm) versus conventional broad‐band UVB with and without dithranol in phototherapy for psoriasis. Journal of the American Academy of Dermatology 1993;28(2 Part 1):227‐31.
Tahir R, Mujtaba G. Comparative efficacy of psoralen ‐ UVA photochemotherapy versus narrow band UVB phototherapy in the treatment of psoriasis. Journal of the College of Physicians & Surgeons ‐ Pakistan 2004;14(10):593‐5.
Young AR. Carcinogenicity of UVB phototherapy assessed. The Lancet 1995;345(8962):1431‐2.
Zanolli MD, Camisa C, Feldman S, Gulliver W, Menter A. Psoriasis: the high notes on current treatment. Program of the American Academy of Dermatology. August 5, 2000.
| Medical term | Explanation |
| Apoptosis | A process of programmed cell death by which cells undergo an ordered sequence of events which lead to the death of the cell. This occurs during growth and development of the organism as a part of normal cell aging or as a response to cellular injury |
| Collagenase | An enzyme which breaks the peptide bonds in collagen |
| Cytokines | Small protein molecules that are secreted by cells of the nervous system or the immune system. They are used in intercellular communication |
| Defective maturation of epidermal keratinocytes | Incomplete formation of keratin (the horny material in nails) due to rapid growth of cells in the epidermal layer of the skin |
| Dilatation of dermal capillaries | Dilation of small blood vessels in the skin |
| Erythrodermic psoriasis | A subtype of psoriasis that affects all body sites |
| Erythrogenic response | Redness of the skin caused by light exposure |
| Extensor aspects | An anatomical term ‐ when a joint bends, the parts of the skin on the opposite side of the joint are called the extensor aspects |
| Hyperkeratosis | Thickening of the stratum corneum (outermost layer of the skin) usually associated with an abnormality of the keratin and an increase of the granular layer of the skin |
| Hyperplasia | An increase in the number of cells |
| Hyperproliferation | An abnormally high rate of proliferation of cells by rapid division |
| Pustular | Lesions containing purulent materials |
| Photosensitiser | Chemical treatments that are used to sensitise the skin and enhance the effect of light treatments |
Figuras y tablas -
Table 1. Glossary of terms used
